Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myelin basic protein and demyelinating diseases.

M K Gupta

    Critical Reviews in Clinical Laboratory Sciences
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Myelin basic protein (MBP) measurement in cerebrospinal fluid aids multiple sclerosis (MS) management. Elevated MBP levels during relapses suggest MS but can also occur in other demyelinating diseases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First results from testing of the full ITER hard x-ray monitor prototype on the ADITYA Upgrade tokamak.

    The Review of scientific instruments·2026
    Same author

    Aerogel as a sustainable lightweight material: A comprehensive review of synthesis, properties, and applications.

    International journal of biological macromolecules·2025
    Same author

    A critical review on the properties and applications of bulk micro and nanobubbles for the degradation of organic pollutants in wastewater treatment.

    The Science of the total environment·2025
    Same author

    PLA based biodegradable bionanocomposite filaments reinforced with nanocellulose: development and analysis of properties.

    Scientific reports·2024
    Same author

    Extraction of nano-crystalline cellulose for development of aerogel: Structural, morphological and antibacterial analysis.

    Heliyon·2024
    Same author

    Role of pinch in Argon impurity transport in ohmic discharges of Aditya-U Tokamak.

    Scientific reports·2023
    Same journal

    Indirect methods for the verification of reference intervals in laboratory medicine.

    Critical reviews in clinical laboratory sciences·2026
    Same journal

    Sustainability and waste reduction in clinical laboratories.

    Critical reviews in clinical laboratory sciences·2026
    Same journal

    Aptamer-based biosensing strategies for influenza virus detection: a systematic and critical review of electrochemical and optical platforms.

    Critical reviews in clinical laboratory sciences·2026
    Same journal

    Advancing patient safety through laboratory quality indicators in clinical pathology.

    Critical reviews in clinical laboratory sciences·2026
    Same journal

    Blood biomarkers for the diagnosis of chorioamnionitis following preterm premature rupture of membranes: a systematic review and meta-analysis of studies since 2020.

    Critical reviews in clinical laboratory sciences·2026
    Same journal

    Single cell mechanodeformation signatures as early biomarkers for hematological malignancies.

    Critical reviews in clinical laboratory sciences·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Immunology
    • Biochemistry

    Background:

    • Myelin basic protein (MBP) is a key component of the myelin sheath.
    • MBP's role in experimental allergic encephalomyelitis (EAE) implicates it in multiple sclerosis (MS) pathogenesis.
    • Accurate MBP measurement in cerebrospinal fluid (CSF) has been challenging due to immunoheterogeneity.

    Purpose of the Study:

    • To review the role of MBP in MS pathogenesis.
    • To discuss advancements in MBP measurement techniques.
    • To evaluate the clinical utility of MBP levels in MS diagnosis and management.

    Main Methods:

    • Review of existing literature on MBP and MS.
    • Discussion of radioimmunoassay techniques for MBP quantification.
    • Analysis of MBP levels in CSF during different MS disease states.

    Related Experiment Videos

    Main Results:

    • Highly sensitive radioimmunoassays now facilitate MBP measurement in MS management.
    • Elevated MBP levels in CSF are observed during MS relapses, particularly within 7 days of symptom onset.
    • Increased MBP levels are not exclusive to MS and are also found in other demyelinating diseases.

    Conclusions:

    • MBP is a significant biomarker in demyelinating diseases, especially MS.
    • Advancements in assay sensitivity have improved MBP's clinical applicability.
    • MBP measurement, while valuable, requires careful interpretation alongside other clinical findings.